Marimed (MRMD) Payables (2011 - 2026)

Marimed (MRMD) has 16 years of Payables data on file, last reported at $18.4 million in Q1 2026.

• On a quarterly basis, Payables fell 1.87% year-over-year to $18.4 million in Q1 2026; TTM through Mar 2026 was $18.4 million, a 1.87% decrease from a year earlier, with the FY2025 full-year figure at $17.1 million, down 6.42% from the prior year.
• Payables for Q1 2026 stood at $18.4 million, up from $17.1 million in the prior quarter.
• Over the last five years, Payables for MRMD reached as high as $18.8 million in Q1 2025 and fell as low as $4.7 million in Q1 2023.
• Historically, Payables has averaged $12.4 million across 5 years, with a median of $11.3 million in 2024.
• Across the five-year window, Payables slumped 43.73% in 2023 and surged 141.63% in 2024, its largest moves.
• Year by year, Payables stood at $10.4 million in 2022, then retreated by 6.5% to $9.7 million in 2023, then jumped by 88.35% to $18.3 million in 2024, then decreased by 6.42% to $17.1 million in 2025, then gained by 7.38% to $18.4 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $18.4 million in Q1 2026, $17.1 million in Q4 2025, and $13.6 million in Q3 2025.